IP Library Granted Patent US 7,753,840
Granted Patent B2
US 7,753,840 · App. 11/515,963 · Granted Jul 13, 2010

Tissue material process for forming bioprosthesis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,753,840
App. No.
11/515,963
Granted
Jul 13, 2010
Kind
B2
Abstract

A biomaterial useful for bioprostheses such as bioprosthetic heart valves is provided in which the fixed tissue has improved elastic properties. The high elastin-containing biomaterial is further characterized by having anisotropic properties wherein the biological material has a greater stiffness in one direction and a greater elasticity in a cross direction. For instance, the biological material has an elastin content of about 30% by weight. In one embodiment, the biological material is vena cava tissue.

Claims (11)

1. A process for forming a bioprosthesis comprising:

excising a tissue having an elastin content greater than about 10% by weight, wherein the tissue is vena cava tissue;

forming the excised tissue into the shape of a heart valve leaflet; and

attaching the heart valve leaflet to a support material of the bioprosthesis, wherein the support material is a heart valve stent or a suture ring.

2. The process of claim 1 , wherein the tissue is an anisotropic material.

3. The process of claim 1 , wherein the excised tissue is formed into the shape of a tricuspid valve leaflet.

4. The process of claim 1 , wherein the excised tissue is formed into the shape of a bicuspid valve leaflet.

5. The process of claim 1 , further comprising excising a section of vena cava, the vena cava section defining a longitudinal direction and a circumferential direction, and opening the section of vena cava with a longitudinal incision, wherein the opened section of vena cava is the vena cava tissue.

6. The process of claim 1 , wherein the vena cava tissue is porcine vena cava tissue.

7. The process of claim 1 , further comprising chemically fixing the tissue.

8. The process of claim 1 , wherein the excised vena cava tissue has an elastin content greater than about 30% by weight.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 1, 2015
From: CLEMSON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036053/0859 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2010
From: CLEMSON UNIVERSITY
To: CLEMSON UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 024542/0343 →
Continuity (3)
Continuation 1072258100 · Nov 24, 2003
Provisional Application 6042919100 · Nov 26, 2002
Related Publication 20070005132A1 · Jan 4, 2007